Preparation method and use of cord blood-derived (CD)133 and brain glioma stem cell antigen carrying dendritic cells

The invention provides a preparation method and use of CD133 and brain glioma stem cell antigen carrying dendritic cells, the use of the CD133 and brain glioma stem cell antigen carrying dendritic cells in the preparation of ant-brain-glioma medicines and a vaccine containing the CD133 and brain gli...

Full description

Saved in:
Bibliographic Details
Main Author SHEN DAQING
Format Patent
LanguageChinese
English
Published 17.08.2011
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The invention provides a preparation method and use of CD133 and brain glioma stem cell antigen carrying dendritic cells, the use of the CD133 and brain glioma stem cell antigen carrying dendritic cells in the preparation of ant-brain-glioma medicines and a vaccine containing the CD133 and brain glioma stem cell antigen carrying dendritic cells. Medicines prepared by using the CD133 and brain glioma stem cell antigen carrying dendritic cells and immune compositions containing the CD133 and brain glioma stem cell antigen carrying dendritic cells can kill brain glioma stem cells, which can arouse relapse of brain glioma, in vivo and in vitro, and thus, it is possible to overcome the medicine resistance of brain glioma and treat the relapse and transfer of brain glioma radically.
Bibliography:Application Number: CN20101608906